Evidence map›Paper›PMID 38762619›Full record

Observational studyActa diabetologica2024

An "out of the box" approach for prevention of ketoacidosis in youth with poorly controlled type 1 diabetes: combined use of insulin pump and long-acting insulin.

Galia Barash, Liat Lerman, Tal Ben-Ari, Shirly Abiri, Zohar Landau, Michal Ben Ami, Avivit Brener, Yael Lebenthal, Orit Pinhas-Hamiel, Kineret Mazor-Aronovitch and 4 more

Abstract readObservational StudyMulticenter Study
In one paragraph

Observational study in Acta diabetologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Galia Barash *Pediatric Endocrinology and Diabetes Institute, Shamir (Assaf Harofeh) Medical Center, Tzrifin, Beer Ya'akov, Israel. galiaba@shamir.gov.il.ORCID http://orcid.org/0000-0003-4413-4150
Liat Lerman *The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Tal Ben-AriFaculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Shirly AbiriFaculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Zohar LandauNational Juvenile Diabetes Center, Maccabi Health Care Services, Ra'anana, Israel.ORCID https://orcid.org/0000-0002-0434-9563
Michal Ben AmiFaculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Avivit BrenerFaculty of Medicine, Tel Aviv University, Tel Aviv, Israel.ORCID https://orcid.org/0000-0002-2742-8264
Yael LebenthalFaculty of Medicine, Tel Aviv University, Tel Aviv, Israel.ORCID http://orcid.org/0000-0001-5963-0574
Orit Pinhas-HamielFaculty of Medicine, Tel Aviv University, Tel Aviv, Israel.ORCID https://orcid.org/0000-0001-8365-8091
Kineret Mazor-AronovitchFaculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Alon HaimFaculty of Health Sciences, Ben-Gurion University of the Negev, Beer‑Sheva, Israel.
Yonatan YeshayahuFaculty of Health Sciences, Ben-Gurion University of the Negev, Beer‑Sheva, Israel.
Liat De VriesFaculty of Medicine, Tel Aviv University, Tel Aviv, Israel.ORCID http://orcid.org/0000-0001-8647-5717
Marianna RachmielPediatric Endocrinology and Diabetes Institute, Shamir (Assaf Harofeh) Medical Center, Tzrifin, Beer Ya'akov, Israel.ORCID http://orcid.org/0000-0002-0852-0831

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPoorly controlled adolescents living with type 1 diabetes (T1D) and pump failure of insulin delivery leading to diabetic ketoacidosis (DKA) are still challenging in the western world.

aimTo investigate the effect of a combination modality of long-acting insulin for basal coverage and a pump for boluses, on the incidence of DKA and glycemic parameters in pediatric and young adults with poorly controlled T1D.

methodsThis multicenter, observational retrospective study included 55 patients (age range 3-25 years, 52.7% males) who were treated with the combination modality for a median of 18 months [(IQR)12,47], as part of their clinical care. Data were retrieved at initiation of the combined modality, after 6 months, and at last visit.

resultsCohort's median age at combination modality initiation was 14.5 years [IQR12.4,17.3], and its median HbA1c level was 9.2% [IQR 8.2,10.2]. The main reasons for combination modality initiation were: (a) concern about sustained hyperglycemia on current management in 41.8%, (b) previous DKA episodes in 30.8%, and (c) refusal to wear a pump continuously in 14.6%. The percent of patients experiencing DKA who used the modality till end decreased from 25.4 to 8.8%. The frequency of DKA events per patient month decreased after 6 months from 0.073 (min 0, max 0.5) to 0.020 (min 0, max 0.5), p = 0.01, and at end to 0.016 (min 0, max 0.25), p = 0.007.

conclusionsThe combination modality of once-daily long-acting insulin and pump for boluses is safe, feasible, and effective in preventing DKA among poorly controlled young people living with T1D, unable or un-willing to use advanced closed pumps.

Indexed as

Diabetes Mellitus, Type 1Diabetic KetoacidosisHypoglycemic AgentsInsulin Infusion SystemsAdolescentAdultBlood GlucoseChildChild, PreschoolFemaleHumansInsulinInsulin, Long-ActingMaleRetrospective StudiesYoung AdultBlood GlucoseHypoglycemic AgentsInsulinInsulin, Long-ActingAdolescentsDiabetic ketoacidosisGlycemic controlPoorly controlledType 1 diabetes

Identifiers

PMID38762619
PMCPMC11486826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.